The Swiss voice in the world since 1935

No cannabis for scientific studies, says parliament

cannabis buds
Legal cannabis has boomed in Switzerland, but the 'real' stuff remains proscribed. Keystone

The Swiss parliament has rejected a motion to allow the use of cannabis in scientific studies investigating the drug’s effects. Opponents saw the motion as a back-door path towards liberalization.

After a narrow victory at the committee stage, the motion was rejected on Monday in the House of Representatives by another slim margin: 96 votes to 93, with two abstentions.

The conservative-right Swiss People’s Party and centrist Christian Democrats voted en masse against the idea, which they saw as an implicit route towards liberalising cannabis consumption.

Supporters of the project, which aimed to make cannabis available for academic studies about the effects of prescribed versions of the drug, had claimed that it would allow for a better understanding of possible health and social problems.

The vote comes after a November 2017 federal decision to block a University of Bern study – requested by the city’s authorities – into possible effects of the regulated sale of cannabis in pharmacies.

+ An in-depth look into Switzerland’s relationship with cannabis

At the time, the Federal Office of Public Health (despite not rejecting the project in principle) said the request could not be granted as “current drugs legislation does not allow the use of cannabis for non-medical reasons […] For such a study to be permitted, the law would have to be supplemented by a special legal provision for scientific pilot projects,” it wrote.

Monday’s decision thus eliminated the possibility, for now, of such a legal provision being enacted.

Growing, consuming and dealing cannabis are all forbidden in Switzerland. In 2008, almost two-thirds of Swiss voters rejected a people’s initiative calling for the decriminalisation of consumption.

Meanwhile, legal cannabis has become a flourishing business in Switzerland since it a 2011 decision to let adults buy and use cannabis with up to 1% tetrahydrocannabinol (THC) – the active ingredient that gets smokers high.

More

Popular Stories

Most Discussed

News

Plane grazes hikers on Monte Rosa, pilot apologises

More

Plane grazes hikers on Monte Rosa

This content was published on A Geneva-registered tourist plane grazed some ski mountaineers on Saturday on a glacier on the Swiss side of the Monte Rosa massif.

Read more: Plane grazes hikers on Monte Rosa
The air in climbing gyms is more polluted than on the streets

More

Air in climbing gyms more polluted than on streets

This content was published on The concentration of potentially harmful chemicals in climbing gyms is sometimes higher than on busy roads, say researchers from Switzerland and Austria.

Read more: Air in climbing gyms more polluted than on streets
Swiss with lower profit in the first quarter

More

SWISS reports lower profit in first quarter

This content was published on Swiss International Air Lines (SWISS) achieved slightly higher sales at the start of the year. However, profits fell sharply, partly due to the late Easter.

Read more: SWISS reports lower profit in first quarter
Significantly less wine is drunk in Switzerland

More

Swiss drink significantly less wine

This content was published on Wine consumption in Switzerland fell by almost 8% in 2024 compared to the previous year. Swiss wines are particularly affected by the decline.

Read more: Swiss drink significantly less wine

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR